Amplifying blood biomarkers with ultrasound to help predict the aggressiveness of prostate cancer 

Presenter: Dr. Roger Zemp
Original Date: Tuesday, May 31, 2016

Join Dr. Roger Zemp to learn about how:
  • Blood biomarkers are used in the detection of prostate cancer but may also offer promise in determining how aggressive a prostate cancer is
  • Current biomarker testing cannot yet predict aggressiveness, in part due to the low levels of informative prostate biomarkers in the blood
  • We are developing technologies that may help (1) amplify the level of such informative biomarkers in the blood using ultrasound and (2) enrich such biomarkers using magnetic trapping and nanoparticles
 

Dr. Roger Zemp's Biography:

Roger Zemp is an Associate Professor of Electrical and Computer Engineering and Biomedical Engineering at the University of Alberta. He earned his BSc in Physics at the University of Alberta in 1998, his MASc from the Institute of Biomaterials and Biomedical Engineering at the University of Toronto in 2000 and his PhD in Biomedical Engineering from the University of California, Davis in 2004. He worked as a postdoctoral fellow with Prof. Lihong Wang at Texas A&M University in Biomedical Optics from 2004-2006 then continued with Prof. Wang in Washington University in St. Louis from 2006-2007. He has been a faculty member at the University of Alberta since 2007. He is the author of 68 journal publications and over 140 conference publications or abstracts. He is on the editorial board of a number of journals and directs a research program with interests in biomedical optics, biomedical ultrasonics, photoacoutsic imaging, and micro- and nano-technologies for biomedicine. 

Expert AngleAbout Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.
More

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.
More

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More


Click here for news archive